Results 161 to 170 of about 92,981 (315)

The nicotinic blocking agents d-tubocurare and alpha-bungarotoxin save motoneurons from naturally occurring death in the absence of neuromuscular blockade [PDF]

, 1995
F Hory-Lee, E Frank
openalex   +1 more source

Experimental approaches to understanding the role of protein phosphorylation in the regulation of neuronal function [PDF]

, 1983
Studies by Earl Sutherland and his colleagues on hormonal regulation of the breakdown of glycogen in liver resulted in the discovery that the first step in the action of many hormones is to increase the synthesis of cAMP by activating adenylate cyclase ...
Kennedy, Mary B.
core  

Recent Advances in Stimuli‐Responsive Conductive Hydrogels for Smart Sensing and Actuation: Properties, Design Strategies, and Applications

Macromolecular Materials and Engineering, EarlyView.
Abstract Conductive hydrogels are a class of multifunctional composites constructed by introducing conductive components into a three‐dimensional polymer network, combining the high water‐content, stretchability, and biocompatibility of traditional hydrogels.
Lulu Li, Xidi Sun, Yuchen Guo, Wen Cheng, Yi Shi, Lijia Pan   +5 more
wiley   +1 more source

MODE OF ACTION OF NEUROMUSCULAR BLOCKING AGENTS * *A paper given at the World Congress of Anaesthesiologists, Scheveningen, Holland, in September 1955.

, 1956
W. D. M. Paton
openalex   +1 more source

Pharmacoeconomic issues related to selection of neuromuscular blocking agents [PDF]

, 1999
P F White
openalex   +1 more source

Tetanus : forgiven, not forgotten [PDF]

, 2004
Tetanus is an illness that is still prevalent although the incidence has markedly decreased largely due to immunisation programmes. The latest four cases managed at St. Luke's hospital over 2001-2002 are presented. All of these patients survived. We give
Mallia Azzopardi, Charles, Piscopo, Tonio V.   +1 more
core  

NEUROMUSCULAR BLOCKING AGENTS

British Journal of Anaesthesia, 1962
W.D.M. Paton, D.R. Ward
openaire   +3 more sources

Prevalence and Clinical Characteristics of the LRRK2 p.L1795F Variant in Central Europeans with Early‐Onset and Familial Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Leucine‐rich repeat kinase 2 (LRRK2) p.L1795F variant was proposed as a genetic risk factor for Parkinson's disease (PD). However, its prevalence, phenotype, and origin remain unknown. Objective The aim was to evaluate the frequency and phenotype of p.L1795F in early‐onset PD (EOPD) and familial PD compared to healthy controls (HC ...
Miriam Ostrozovicova, Gertrud Tamas, Agsha Atputhavadivel, Petr Dusek, Milan Grofik, Vladimir Han, Petr Holly, Robert Jech, Katarina Kalinova, Peter Klivenyi, Norbert Kovacs, Kristina Kulcsarova, Egon Kurca, Alexandra Lackova, Hamin Lee, Patrick Lewis, Veronika Magocova, Maria Marekova, David Murphy, Ai Nagano, Jan Necpal, David Pinter, Miroslava Rabajdova, Evzen Ruzicka, Tereza Serranova, Katarzyna Smilowska, Krisztina Soos, Igor Straka, Tatiana Svorenova, Peter Valkovic, Katerina Zarubova, Zuzana Gdovinova, Henry Houlden, Mie Rizig, Matej Skorvanek, on behalf of the CEGEMOD consortium   +35 more
wiley   +1 more source

Advancements in Magnesium Applications, Biocompatible Implants to Nanoparticles in Medicine and Biomedical Innovations

MetalMat, EarlyView.
Magnesium (Mg) and its alloys are identified as prospective materials for orthopedic and cardiovascular applications because of their bio‐corrosiveness and ability to stimulate tissue reparative processes. Although compared with traditional metals, Mg is biocompatible; however, it has various problems that stem from its biodegradation nature, for ...
Muhammad Mubeen, Salman Khalid, Mohammad Tabish, Mubashar Mahmood, Muhammad Jawad, Muhammad Uzair Malik, Ghulam Yasin   +6 more
wiley   +1 more source

ANTAGONISTS TO NEUROMUSCULAR BLOCKING AGENTS: An Experimental Study

, 1968
Barbara J Pleuvry, A.R. Hunter
openalex   +1 more source